Daehwarojatan Tablets (Losartan Potassium)
Losartan Potassium 50mg
Tablet · Prescription medication
Daehwa Pharmaceutical Co., Ltd.
MFDS item code 201500533 · Approved 2015.01.30
This product's status changed to Approval withdrawn on 2024.11.29. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of hypertension and kidney disease in patients with type 2 diabetes accompanied by hypertension
This medication is used to treat hypertension and helps prevent the progression of kidney disease in patients with type 2 diabetes, particularly those with hypertension. Therefore, it is used to reduce complications associated with hypertension and to protect kidney function, thereby improving the patient's health.
This medicine may be taken with or without food, but it is recommended that it be taken at the same time each day. Adults with hypertension: The recommended initial and maintenance dose is losartan potassium 50 mg orally once daily. The maximum blood pressure-lowering effect occurs 3 ∼ 6 weeks after starting treatment. If the treatment effect is insufficient, the same dose may be divided and administered orally twice daily, or, if necessary, increased to 100 mg once daily. If blood pressure is not controlled with this medicine alone, it may be administered in combination with another antihypertensive medicine (e.g., a low-dose diuretic). An additive effect has been observed with concomitant administration of hydrochlorothiazide. Diabetic nephropathy in patients with type 2 diabetes and hypertension: The usual adult dose of this medicine is 50 mg once daily. Depending on blood pressure, the dose may be increased to 100 mg once daily. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered concomitantly with insulin and commonly used antidiabetic agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). No initial dose adjustment is necessary in elderly patients aged 75 years or younger. For elderly patients over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. Creatinine clearance 20 ∼ 50 mL/min: No initial dose adjustment is necessary. Creatinine clearance < 20 mL/min and patients on dialysis: An initial dose of 25 mg of this medicine once daily is recommended. For patients who may have reduced intravascular effective blood volume (e.g., patients receiving diuretic treatment), an initial dose of 25 mg of this medicine once daily is recommended (see Precautions for Use). Consider administering a lower dose to patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
Children and adolescents aged 6 years or older, weighing 20 kg or more but less than 50 kg, who can swallow tablets: The recommended dose is 25 mg of this medicine once daily, which may be increased to a maximum of 50mg once daily depending on the patient's blood pressure response. Children and adolescents aged 6 years or older, weighing 50 kg or more: The usual recommended dose is 50 mg of this medicine once daily, which may be increased to a maximum of 100 mg once daily depending on the patient's blood pressure response. Pediatric patients under 6 years of age: Not recommended. Pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.
This medication can cause serious harm to the fetus and newborn if taken during pregnancy; therefore, it should be discontinued immediately upon confirmation of pregnancy. Patients who are allergic to this drug, pregnant women, those with severe liver dysfunction, and patients with certain genetic disorders should not take this medication. Elderly patients, patients with high serum potassium levels, patients with impaired liver or kidney function, and those with cardiovascular diseases should use this medication with caution. This drug is generally considered safe; however, side effects such as dizziness, muscle spasms, cough, and dyspepsia may occur. Consult a doctor if any unusual symptoms appear. Patients with liver or kidney issues should have their condition monitored periodically while taking this medication, as there is a risk of blood pressure dropping too low or worsening kidney function. This medication may increase potassium levels, so it is advisable not to take it with potassium supplements or medications containing potassium, and grapefruit juice should also be avoided. Women who are pregnant or breastfeeding are advised not to take this medication, and breastfeeding should be discontinued during its use. This medication is not to be used in children under 6 years of age or in children with severely impaired kidney function. Overdosing may lead to hypotension and arrhythmias, so it is essential to adhere strictly to the prescribed dosage. If an overdose occurs, seek medical attention immediately. During treatment, regular checks of blood pressure, kidney function, and electrolyte levels are required, and caution is advised when driving or operating hazardous machinery due to the risk of dizziness. Store safely out of the reach of children and do not transfer to another container.
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly sealed container to protect it from air and moisture. It is recommended to maintain the storage temperature between 1 degree and 30 degrees Celsius to preserve the effectiveness and safety of the medication for a long time.
White oval film-coated tablets
10 tablets/blister x 3, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Losartan Potassium 50mg
Tablet · Prescription medication
Daehwa Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
DaeWon Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Korea United Pharm, Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
HK Inno.N Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
IYON Pharmaceuticals Co., Ltd.
Losartan Potassium
Prescription medication
JW ShinYak Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Kukje Pharmaceutical Co., Ltd.

Losartan Potassium 50mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.